Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter

Zhicheng Lin, George R. Uhl

Research output: Contribution to journalArticle

Abstract

Ala and Gly substitutions for Pro 101 (P101) located in transmembrane domain 2 of the dopamine transporter (DAT) abolished transport activity but did not disrupt plasma membrane expression. Due to the high conservation of P101 in all neurotransmitter transporters and the capability of Pro to add flexibility to helices, we hypothesized that P101 contributes to the dynamic feature of substrate translocation. To test this hypothesis, here we analysed transport activity for DAT mutants where this Pro was mutated into different amino acids, including Ser, Val, Leu and Phe. The transmembrane domain 2 helix of P101F, unlike the other mutants, was computationally predicted to have a Van der Waals energy threefold higher than the wild-type helix. P101F mutant expression was consistently disrupted in COS cells. Among all the other mutants that express normally, P101V, with a side-chain size close to that of Pro, restores the transport activity of P101A by sevenfold. Most importantly, P101V, P101L and P101S display negative-dosage effects on dopamine (DA) transport, i.e. the velocity-concentration curve for DA uptake does not show a plateau with increasing [DA] but rather peaks and then goes down. These data support the view that P101 of DAT plays an essential role in DA translocation.

Original languageEnglish (US)
Pages (from-to)276-287
Number of pages12
JournalJournal of Neurochemistry
Volume94
Issue number1
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Dopamine Plasma Membrane Transport Proteins
Proline
Dopamine
Mutation
Neurotransmitter Transport Proteins
COS Cells
Cell membranes
Conservation
Substitution reactions
Display devices
Cell Membrane
Amino Acids
Substrates

Keywords

  • Dynamics
  • Expression
  • Molecular modeling
  • Monoamine transport
  • Mutagenesis

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter. / Lin, Zhicheng; Uhl, George R.

In: Journal of Neurochemistry, Vol. 94, No. 1, 2005, p. 276-287.

Research output: Contribution to journalArticle

@article{94a625943cfb48e6a99ba138fd160736,
title = "Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter",
abstract = "Ala and Gly substitutions for Pro 101 (P101) located in transmembrane domain 2 of the dopamine transporter (DAT) abolished transport activity but did not disrupt plasma membrane expression. Due to the high conservation of P101 in all neurotransmitter transporters and the capability of Pro to add flexibility to helices, we hypothesized that P101 contributes to the dynamic feature of substrate translocation. To test this hypothesis, here we analysed transport activity for DAT mutants where this Pro was mutated into different amino acids, including Ser, Val, Leu and Phe. The transmembrane domain 2 helix of P101F, unlike the other mutants, was computationally predicted to have a Van der Waals energy threefold higher than the wild-type helix. P101F mutant expression was consistently disrupted in COS cells. Among all the other mutants that express normally, P101V, with a side-chain size close to that of Pro, restores the transport activity of P101A by sevenfold. Most importantly, P101V, P101L and P101S display negative-dosage effects on dopamine (DA) transport, i.e. the velocity-concentration curve for DA uptake does not show a plateau with increasing [DA] but rather peaks and then goes down. These data support the view that P101 of DAT plays an essential role in DA translocation.",
keywords = "Dynamics, Expression, Molecular modeling, Monoamine transport, Mutagenesis",
author = "Zhicheng Lin and Uhl, {George R.}",
year = "2005",
doi = "10.1111/j.1471-4159.2005.03196.x",
language = "English (US)",
volume = "94",
pages = "276--287",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter

AU - Lin, Zhicheng

AU - Uhl, George R.

PY - 2005

Y1 - 2005

N2 - Ala and Gly substitutions for Pro 101 (P101) located in transmembrane domain 2 of the dopamine transporter (DAT) abolished transport activity but did not disrupt plasma membrane expression. Due to the high conservation of P101 in all neurotransmitter transporters and the capability of Pro to add flexibility to helices, we hypothesized that P101 contributes to the dynamic feature of substrate translocation. To test this hypothesis, here we analysed transport activity for DAT mutants where this Pro was mutated into different amino acids, including Ser, Val, Leu and Phe. The transmembrane domain 2 helix of P101F, unlike the other mutants, was computationally predicted to have a Van der Waals energy threefold higher than the wild-type helix. P101F mutant expression was consistently disrupted in COS cells. Among all the other mutants that express normally, P101V, with a side-chain size close to that of Pro, restores the transport activity of P101A by sevenfold. Most importantly, P101V, P101L and P101S display negative-dosage effects on dopamine (DA) transport, i.e. the velocity-concentration curve for DA uptake does not show a plateau with increasing [DA] but rather peaks and then goes down. These data support the view that P101 of DAT plays an essential role in DA translocation.

AB - Ala and Gly substitutions for Pro 101 (P101) located in transmembrane domain 2 of the dopamine transporter (DAT) abolished transport activity but did not disrupt plasma membrane expression. Due to the high conservation of P101 in all neurotransmitter transporters and the capability of Pro to add flexibility to helices, we hypothesized that P101 contributes to the dynamic feature of substrate translocation. To test this hypothesis, here we analysed transport activity for DAT mutants where this Pro was mutated into different amino acids, including Ser, Val, Leu and Phe. The transmembrane domain 2 helix of P101F, unlike the other mutants, was computationally predicted to have a Van der Waals energy threefold higher than the wild-type helix. P101F mutant expression was consistently disrupted in COS cells. Among all the other mutants that express normally, P101V, with a side-chain size close to that of Pro, restores the transport activity of P101A by sevenfold. Most importantly, P101V, P101L and P101S display negative-dosage effects on dopamine (DA) transport, i.e. the velocity-concentration curve for DA uptake does not show a plateau with increasing [DA] but rather peaks and then goes down. These data support the view that P101 of DAT plays an essential role in DA translocation.

KW - Dynamics

KW - Expression

KW - Molecular modeling

KW - Monoamine transport

KW - Mutagenesis

UR - http://www.scopus.com/inward/record.url?scp=21344452535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344452535&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2005.03196.x

DO - 10.1111/j.1471-4159.2005.03196.x

M3 - Article

C2 - 15953370

AN - SCOPUS:21344452535

VL - 94

SP - 276

EP - 287

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 1

ER -